Dissemin is shutting down on January 1st, 2025

Published in

Rockefeller University Press, Journal of Experimental Medicine, 6(219), 2022

DOI: 10.1084/jem.20220028

Links

Tools

Export citation

Search in Google Scholar

A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes

Journal article published in 2022 by Paul Bastard ORCID, Kuang-Chih Hsiao ORCID, Qian Zhang ORCID, Jeremy Choin ORCID, Emma Best ORCID, Jie Chen ORCID, Adrian Gervais ORCID, Lucy Bizien ORCID, Marie Materna ORCID, Christine Harmant ORCID, Maguelonne Roux ORCID, Nicola L. Hawley ORCID, Daniel E. Weeks ORCID, Stephen T. McGarvey ORCID, Karla Sandoval ORCID and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Globally, autosomal recessive IFNAR1 deficiency is a rare inborn error of immunity underlying susceptibility to live attenuated vaccine and wild-type viruses. We report seven children from five unrelated kindreds of western Polynesian ancestry who suffered from severe viral diseases. All the patients are homozygous for the same nonsense IFNAR1 variant (p.Glu386*). This allele encodes a truncated protein that is absent from the cell surface and is loss-of-function. The fibroblasts of the patients do not respond to type I IFNs (IFN-α2, IFN-ω, or IFN-β). Remarkably, this IFNAR1 variant has a minor allele frequency >1% in Samoa and is also observed in the Cook, Society, Marquesas, and Austral islands, as well as Fiji, whereas it is extremely rare or absent in the other populations tested, including those of the Pacific region. Inherited IFNAR1 deficiency should be considered in individuals of Polynesian ancestry with severe viral illnesses.